Ads
related to: cholesterol drugs zetia dosage schedule for men mayo clinicRanked at No. 20 on the 2020 Disruptor 50 list. - CNBC
- Healthcare Professionals
GoodRx® Can Help You Get Major
Savings For Your Patients
- Flu Shot & Med Discounts
Get a Free Discount for Your
Flu Shot or Prescriptions
- How GoodRx® Works
Get Rx Coupons, Save Up to 80%
No Commitment & No Fees
- Do I Need Insurance?
No! Compare Our Prices to Your
Insurance & Get the Biggest Savings
- Healthcare Professionals
Search results
Results from the WOW.Com Content Network
Ezetimibe, sold under the brand name Zetia among others, is a medication used to treat high blood cholesterol and certain other lipid abnormalities. [3] [4] Generally it is used together with dietary changes and a statin. [5] Alone, it is less preferred than a statin. [4] It is taken by mouth. [4]
Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug.In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [1]
It is a combination of ezetimibe (known as Zetia in the United States) and the statin drug simvastatin (known as Zocor in the US). Ezetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.
Feb. 16—With those New Year's resolutions six weeks behind us, some people may have reverted to less healthy ways of eating. Heart Month is a great time to remind yourself why a healthy diet is ...
Cholesterol synthesis appears to occur mostly at night, [140] so statins with short half-lives are usually taken at night to maximize their effect. Studies have shown greater LDL and total cholesterol reductions in the short-acting simvastatin taken at night rather than the morning, [141] [142] but have shown no difference in the long-acting ...
The drug stops this from happening, essentially shooting the messenger. Nissen's study was meant to test the safety of lepodisiran. It was small, including just 48 adults in the U.S. and Singapore.